Delivery Order SPE2DB20D1110-SPE2DB24FK28G
Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, SPE2DB20D1004|SPE2DB24FF6G7, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of LINZESS 290 MCG CAPSULE UU 30S. The contract has a firm fixed price of $1,626.61 and an ultimate completion date of March 19, 2024. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.94 Firm Fixed Price Delivery Order is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025 and was awarded on July 1, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, with ID SPE2DB22D1200|SPE2DB25FM8UR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,816.99 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a prescription medication. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $1,654.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LINZESS 290 MCG CAPSULE, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024, and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL81T, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S, with a ceiling value of $10,457.45. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award, SPE2DB20D2002|SPE2DB24FL50S, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,201.65, is a Firm Fixed Price Delivery Order for the supply of LINZESS 290 MCG CAPSULE UU 30S, a medical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,700.65, is a firm fixed-price delivery order for LINZESS 290 MCG CAPSULE UU 30S. The contract has an ultimate completion date of June 13, 2025 and was awarded on June 12, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award, with ID SPE2DB22D2009|SPE2DB24FL9LY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,326.95 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,289.57 firm fixed-price delivery order contract is for the supply of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,337.16, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, with a completion date of December 2, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...